Literature DB >> 11751444

Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas.

U Peters1, K A McGlynn, N Chatterjee, E Gunter, M Garcia-Closas, N Rothman, R Sinha.   

Abstract

Experimental studies suggest that vitamin D and calcium protect against cancer by reducing proliferation and inducing differentiation. The effects of vitamin D and calcium may be mediated by the vitamin D receptor (VDR), which is encoded by the VDR gene. The present study investigated whether calcium intake and serum vitamin D, as an integrated measure of intake and endogenous production, were associated with risk of colorectal adenoma, known precursors of invasive colorectal cancer. In addition, the interrelation among vitamin D, calcium, and FokI polymorphism of the VDR gene was investigated. Persons (239) with histologically confirmed colorectal adenomas and 228 control individuals without colorectal adenomas confirmed by sigmoidoscopy were enrolled in this case control study conducted at the National Naval Medical Center, Bethesda, MD. We observed an inverse association of serum 25-OH vitamin D [25-(OH)D] with colorectal adenoma. With each 10 ng/ml increase of serum 25-(OH)D, the risk of colorectal adenoma decreased by 26% (odds ratio 0.74, 95% confidence interval 0.60-0.92). The results provided limited evidence for a weak association between calcium intake and colorectal adenoma (odds ratio 0.97, 95% confidence interval 0.93-1.01 per each 100-mg calcium intake). However, the inverse association of serum 25-(OH)D with colorectal adenoma is suggested to be stronger in subjects with calcium intake above the median (P for multiplicative interaction 0.13). The VDR FokI polymorphism was not significantly associated with colorectal adenoma and did not modify the effect of vitamin D or calcium. In conclusion, the study results suggested a protective effect for vitamin D on colorectal adenoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751444

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  47 in total

1.  Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study.

Authors:  Veronika Fedirko; Roberd M Bostick; Michael Goodman; W Dana Flanders; Myron D Gross
Journal:  Am J Epidemiol       Date:  2010-07-22       Impact factor: 4.897

2.  Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence.

Authors:  Elizabeth T Jacobs; David S Alberts; Jose Benuzillo; Bruce W Hollis; Patricia A Thompson; María Elena Martínez
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-12       Impact factor: 4.292

3.  Gene-diet interactions and their impact on colorectal cancer risk.

Authors:  Elizabeth D Kantor; Edward L Giovannucci
Journal:  Curr Nutr Rep       Date:  2015-03

4.  Vitamin D Deficiency Adds an Element of Risk to Insulin Resistance in Colorectal Neoplasms.

Authors:  Myong Ki Baeg; Myung-Gyu Choi; Sun-Hye Ko; Bo-Geun Park; Kyung-Do Han; Jae Myung Park; Bo-In Lee; In-Seok Lee; Sang-Woo Kim
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

5.  Circulating vitamin D and colorectal adenoma in asymptomatic average-risk individuals who underwent first screening colonoscopy: a case-control study.

Authors:  Sung Noh Hong; Jeong Hwan Kim; Won Hyeok Choe; Sun-Young Lee; Dong Choon Seol; Hee-Won Moon; Mina Hur; Yeo-Min Yun; In Kyung Sung; Hyung Seok Park; Chan Sup Shim
Journal:  Dig Dis Sci       Date:  2011-10-08       Impact factor: 3.199

6.  Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry.

Authors:  Jenny N Poynter; Elizabeth T Jacobs; Jane C Figueiredo; Won H Lee; David V Conti; Peter T Campbell; A Joan Levine; Paul Limburg; Loic Le Marchand; Michelle Cotterchio; Polly A Newcomb; John D Potter; Mark A Jenkins; John L Hopper; David J Duggan; John A Baron; Robert W Haile
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01-19       Impact factor: 4.254

7.  Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial.

Authors:  Veronika Fedirko; Roberd M Bostick; Qi Long; W Dana Flanders; Marjorie L McCullough; Eduard Sidelnikov; Carrie R Daniel; Robin E Rutherford; Aasma Shaukat
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

Review 8.  Diet and supplements and their impact on colorectal cancer.

Authors:  Marinos Pericleous; Dalvinder Mandair; Martyn E Caplin
Journal:  J Gastrointest Oncol       Date:  2013-12

Review 9.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

10.  Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study.

Authors:  Mazda Jenab; H Bas Bueno-de-Mesquita; Pietro Ferrari; Franzel J B van Duijnhoven; Teresa Norat; Tobias Pischon; Eugène H J M Jansen; Nadia Slimani; Graham Byrnes; Sabina Rinaldi; Anne Tjønneland; Anja Olsen; Kim Overvad; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sophie Morois; Rudolf Kaaks; Jakob Linseisen; Heiner Boeing; Manuela M Bergmann; Antonia Trichopoulou; Gesthimani Misirli; Dimitrios Trichopoulos; Franco Berrino; Paolo Vineis; Salvatore Panico; Domenico Palli; Rosario Tumino; Martine M Ros; Carla H van Gils; Petra H Peeters; Magritt Brustad; Eiliv Lund; María-José Tormo; Eva Ardanaz; Laudina Rodríguez; Maria-José Sánchez; Miren Dorronsoro; Carlos A Gonzalez; Göran Hallmans; Richard Palmqvist; Andrew Roddam; Timothy J Key; Kay-Tee Khaw; Philippe Autier; Pierre Hainaut; Elio Riboli
Journal:  BMJ       Date:  2010-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.